APO Research
Talk to an analyst

APO RESEARCH · REPORT

Leucine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Leucine Market Outlook and Growth Opportunities 2026

5 July 2026191 pages

Choose your research edition.

Industry ResearchLeucine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Leucine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Leucine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leucine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Leucine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Leucine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Leucine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Leucine market include Ajinomoto Group, Evonik, CJ, KYOWA, Hubei Bafeng Pharmaceutical, Jinghai Amino Acid, JIRONG PHARM, Jiahe Biotech and ChuyuanGroup, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Leucine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Leucine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Leucine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Leucine market size, projected growth trends, production technologies, key applications, and end-use industries.

Leucine Segment by Company

Ajinomoto Group

Evonik

CJ

KYOWA

Hubei Bafeng Pharmaceutical

Jinghai Amino Acid

JIRONG PHARM

Jiahe Biotech

ChuyuanGroup

Siwei Amino Acid

SHINE STAR（HUBEI）BLOLOGICAL

JiangsuShenhua Pharmaceutical

ZhangjiagangxingyuTechnology

Leucine Segment by Type

Food Grade

Feed Grade

Pharmaceutical Grade

Leucine Segment by Application

Food

Feed

Pharmaceuticals

Leucine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Leucine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Leucine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Leucine significant trends, drivers, influence factors in global and regions.

6. To analyze Leucine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leucine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leucine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leucine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Leucine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Leucine industry.

Chapter 3: Detailed analysis of Leucine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Leucine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Leucine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Leucine Industry Trends Table 2. Leucine Industry Drivers Table 3. Leucine Industry Opportunities and Challenges Table 4. Leucine Industry Restraints Table 5. Global Leucine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Leucine Revenue Share by Company (2021-2026) Table 7. Global Leucine Sales Volume by Company (kt) & (2021-2026) Table 8. Global Leucine Sales Volume Share by Company (2021-2026) Table 9. Global Leucine Average Price (USD/t) of Company (2021-2026) Table 10. Global Leucine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Leucine Key Company Manufacturing Base & Headquarters Table 12. Global Leucine Company, Product Type & Application Table 13. Global Leucine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Leucine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Food Grade Table 18. Significant Companies of Feed Grade Table 19. Significant Companies of Pharmaceutical Grade Table 20. Global Leucine Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 21. Global Leucine Sales Volume by Type (2021-2026) & (kt) Table 22. Global Leucine Sales Volume by Type (2027-2032) & (kt) Table 23. Global Leucine Sales Volume Share by Type (2021-2026) Table 24. Global Leucine Sales Volume Share by Type (2027-2032) Table 25. Global Leucine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Leucine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Leucine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Leucine Sales Value Share by Type (2021-2026) Table 29. Global Leucine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Food Table 31. Significant Companies of Feed Table 32. Significant Companies of Pharmaceuticals Table 33. Global Leucine Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 34. Global Leucine Sales Volume by Application (2021-2026) & (kt) Table 35. Global Leucine Sales Volume by Application (2027-2032) & (kt) Table 36. Global Leucine Sales Volume Share by Application (2021-2026) Table 37. Global Leucine Sales Volume Share by Application (2027-2032) Table 38. Global Leucine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Leucine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Leucine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Leucine Sales Value Share by Application (2021-2026) Table 42. Global Leucine Sales Value Share by Application (2027-2032) Table 43. Global Leucine Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 44. Global Leucine Sales by Region (2021-2026) & (kt) Table 45. Global Leucine Sales Market Share by Region (2021-2026) Table 46. Global Leucine Sales by Region (2027-2032) & (kt) Table 47. Global Leucine Sales Market Share by Region (2027-2032) Table 48. Global Leucine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Leucine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Leucine Sales Value Share by Region (2021-2026) Table 51. Global Leucine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Leucine Sales Value Share by Region (2027-2032) Table 53. Global Leucine Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Leucine Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Leucine Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 56. Global Leucine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Leucine Sales by Country (2021-2026) & (kt) Table 58. Global Leucine Sales Market Share by Country (2021-2026) Table 59. Global Leucine Sales by Country (2027-2032) & (kt) Table 60. Global Leucine Sales Market Share by Country (2027-2032) Table 61. Global Leucine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Leucine Sales Value Market Share by Country (2021-2026) Table 63. Global Leucine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Leucine Sales Value Market Share by Country (2027-2032) Table 65. Ajinomoto Group Company Information Table 66. Ajinomoto Group Business Overview Table 67. Ajinomoto Group Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. Ajinomoto Group Leucine Product Portfolio Table 69. Ajinomoto Group Recent Development Table 70. Evonik Company Information Table 71. Evonik Business Overview Table 72. Evonik Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Evonik Leucine Product Portfolio Table 74. Evonik Recent Development Table 75. CJ Company Information Table 76. CJ Business Overview Table 77. CJ Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. CJ Leucine Product Portfolio Table 79. CJ Recent Development Table 80. KYOWA Company Information Table 81. KYOWA Business Overview Table 82. KYOWA Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. KYOWA Leucine Product Portfolio Table 84. KYOWA Recent Development Table 85. Hubei Bafeng Pharmaceutical Company Information Table 86. Hubei Bafeng Pharmaceutical Business Overview Table 87. Hubei Bafeng Pharmaceutical Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Hubei Bafeng Pharmaceutical Leucine Product Portfolio Table 89. Hubei Bafeng Pharmaceutical Recent Development Table 90. Jinghai Amino Acid Company Information Table 91. Jinghai Amino Acid Business Overview Table 92. Jinghai Amino Acid Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Jinghai Amino Acid Leucine Product Portfolio Table 94. Jinghai Amino Acid Recent Development Table 95. JIRONG PHARM Company Information Table 96. JIRONG PHARM Business Overview Table 97. JIRONG PHARM Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. JIRONG PHARM Leucine Product Portfolio Table 99. JIRONG PHARM Recent Development Table 100. Jiahe Biotech Company Information Table 101. Jiahe Biotech Business Overview Table 102. Jiahe Biotech Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Jiahe Biotech Leucine Product Portfolio Table 104. Jiahe Biotech Recent Development Table 105. ChuyuanGroup Company Information Table 106. ChuyuanGroup Business Overview Table 107. ChuyuanGroup Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. ChuyuanGroup Leucine Product Portfolio Table 109. ChuyuanGroup Recent Development Table 110. Siwei Amino Acid Company Information Table 111. Siwei Amino Acid Business Overview Table 112. Siwei Amino Acid Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Siwei Amino Acid Leucine Product Portfolio Table 114. Siwei Amino Acid Recent Development Table 115. SHINE STAR（HUBEI）BLOLOGICAL Company Information Table 116. SHINE STAR（HUBEI）BLOLOGICAL Business Overview Table 117. SHINE STAR（HUBEI）BLOLOGICAL Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. SHINE STAR（HUBEI）BLOLOGICAL Leucine Product Portfolio Table 119. SHINE STAR（HUBEI）BLOLOGICAL Recent Development Table 120. JiangsuShenhua Pharmaceutical Company Information Table 121. JiangsuShenhua Pharmaceutical Business Overview Table 122. JiangsuShenhua Pharmaceutical Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. JiangsuShenhua Pharmaceutical Leucine Product Portfolio Table 124. JiangsuShenhua Pharmaceutical Recent Development Table 125. ZhangjiagangxingyuTechnology Company Information Table 126. ZhangjiagangxingyuTechnology Business Overview Table 127. ZhangjiagangxingyuTechnology Leucine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. ZhangjiagangxingyuTechnology Leucine Product Portfolio Table 129. ZhangjiagangxingyuTechnology Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Leucine Distributors List Table 133. Leucine Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Leucine Product Image Figure 2. Global Leucine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leucine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Leucine Sales (2021-2032) & (kt) Figure 5. Global Leucine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Leucine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Food Grade Image Figure 10. Feed Grade Image Figure 11. Pharmaceutical Grade Image Figure 12. Global Leucine Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 13. Global Leucine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Leucine Sales Volume Share by Type (2021-2032) Figure 15. Global Leucine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Leucine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Leucine Sales Value Share by Type (2021-2032) Figure 18. Food Image Figure 19. Feed Image Figure 20. Pharmaceuticals Image Figure 21. Global Leucine Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 22. Global Leucine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Leucine Sales Volume Share by Application (2021-2032) Figure 24. Global Leucine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Leucine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Leucine Sales Value Share by Application (2021-2032) Figure 27. Global Leucine Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 28. Global Leucine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Leucine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Leucine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Leucine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Leucine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Leucine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Leucine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Leucine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Leucine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Leucine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Leucine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Leucine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Leucine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Leucine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Leucine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Leucine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Leucine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Leucine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade
  • Feed Grade
  • Pharmaceutical Grade
Applications
  • Food
  • Feed
  • Pharmaceuticals
Companies covered
  • Ajinomoto Group
  • Evonik
  • CJ
  • KYOWA
  • Hubei Bafeng Pharmaceutical
  • Jinghai Amino Acid
  • JIRONG PHARM
  • Jiahe Biotech
  • ChuyuanGroup
  • Siwei Amino Acid
  • SHINE STAR（HUBEI）BLOLOGICAL
  • JiangsuShenhua Pharmaceutical
  • ZhangjiagangxingyuTechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Leucine Sales Value (2021-2032)
  4. 1.2.2 Global Leucine Sales Volume (2021-2032)
  5. 1.2.3 Global Leucine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Leucine Market Dynamics
  1. 2.1 Leucine Industry Trends
  2. 2.2 Leucine Industry Drivers
  3. 2.3 Leucine Industry Opportunities and Challenges
  4. 2.4 Leucine Industry Restraints
3 Leucine Market by Company
  1. 3.1 Global Leucine Company Revenue Ranking in 2025
  2. 3.2 Global Leucine Revenue by Company (2021-2026)
  3. 3.3 Global Leucine Sales Volume by Company (2021-2026)
  4. 3.4 Global Leucine Average Price by Company (2021-2026)
  5. 3.5 Global Leucine Company Ranking (2024-2026)
  6. 3.6 Global Leucine Company Manufacturing Base and Headquarters
  7. 3.7 Global Leucine Company Product Type and Application
  8. 3.8 Global Leucine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Leucine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Leucine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Leucine Market by Type
  1. 4.1 Leucine Type Introduction
  2. 4.1.1 Food Grade
  3. 4.1.2 Feed Grade
  4. 4.1.3 Pharmaceutical Grade
  5. 4.2 Global Leucine Sales Volume by Type
  6. 4.2.1 Global Leucine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Leucine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Leucine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Leucine Sales Value by Type
  10. 4.3.1 Global Leucine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Leucine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Leucine Sales Value Share by Type (2021-2032)
5 Leucine Market by Application
  1. 5.1 Leucine Application Introduction
  2. 5.1.1 Food
  3. 5.1.2 Feed
  4. 5.1.3 Pharmaceuticals
  5. 5.2 Global Leucine Sales Volume by Application
  6. 5.2.1 Global Leucine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Leucine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Leucine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Leucine Sales Value by Application
  10. 5.3.1 Global Leucine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Leucine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Leucine Sales Value Share by Application (2021-2032)
6 Leucine Regional Sales and Value Analysis
  1. 6.1 Global Leucine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Leucine Sales by Region (2021-2032)
  3. 6.2.1 Global Leucine Sales by Region: 2021-2026
  4. 6.2.2 Global Leucine Sales by Region (2027-2032)
  5. 6.3 Global Leucine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Leucine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Leucine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Leucine Sales Value by Region (2027-2032)
  9. 6.5 Global Leucine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Leucine Sales Value (2021-2032)
  12. 6.6.2 North America Leucine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Leucine Sales Value (2021-2032)
  15. 6.7.2 Europe Leucine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Leucine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Leucine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Leucine Sales Value (2021-2032)
  21. 6.9.2 South America Leucine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Leucine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Leucine Sales Value Share by Country, 2025 VS 2032
7 Leucine Country-level Sales and Value Analysis
  1. 7.1 Global Leucine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Leucine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Leucine Sales by Country (2021-2032)
  4. 7.3.1 Global Leucine Sales by Country (2021-2026)
  5. 7.3.2 Global Leucine Sales by Country (2027-2032)
  6. 7.4 Global Leucine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Leucine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Leucine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Leucine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Leucine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Leucine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Leucine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Leucine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Leucine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Leucine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Leucine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Leucine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Leucine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Leucine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Leucine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Leucine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Leucine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Leucine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Leucine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Leucine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Leucine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Leucine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Leucine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Leucine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Leucine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Leucine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Leucine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Leucine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Leucine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Leucine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Leucine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Leucine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Leucine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Leucine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Leucine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Leucine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Leucine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Leucine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Leucine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Leucine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Leucine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Leucine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Leucine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Leucine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Leucine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Leucine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Leucine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Leucine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Leucine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Leucine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Leucine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Leucine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Leucine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Leucine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Leucine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Leucine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Leucine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Leucine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Leucine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Leucine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Leucine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Leucine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Leucine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Leucine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Leucine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Leucine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Leucine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Leucine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Leucine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Leucine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Leucine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Leucine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Leucine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Leucine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Leucine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Leucine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Leucine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Leucine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Leucine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Leucine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Leucine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Leucine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Leucine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Leucine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Leucine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Leucine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Leucine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajinomoto Group
  2. 8.1.1 Ajinomoto Group Company Information
  3. 8.1.2 Ajinomoto Group Business Overview
  4. 8.1.3 Ajinomoto Group Leucine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ajinomoto Group Leucine Product Portfolio
  6. 8.1.5 Ajinomoto Group Recent Developments
  7. 8.2 Evonik
  8. 8.2.1 Evonik Company Information
  9. 8.2.2 Evonik Business Overview
  10. 8.2.3 Evonik Leucine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Evonik Leucine Product Portfolio
  12. 8.2.5 Evonik Recent Developments
  13. 8.3 CJ
  14. 8.3.1 CJ Company Information
  15. 8.3.2 CJ Business Overview
  16. 8.3.3 CJ Leucine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CJ Leucine Product Portfolio
  18. 8.3.5 CJ Recent Developments
  19. 8.4 KYOWA
  20. 8.4.1 KYOWA Company Information
  21. 8.4.2 KYOWA Business Overview
  22. 8.4.3 KYOWA Leucine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 KYOWA Leucine Product Portfolio
  24. 8.4.5 KYOWA Recent Developments
  25. 8.5 Hubei Bafeng Pharmaceutical
  26. 8.5.1 Hubei Bafeng Pharmaceutical Company Information
  27. 8.5.2 Hubei Bafeng Pharmaceutical Business Overview
  28. 8.5.3 Hubei Bafeng Pharmaceutical Leucine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Bafeng Pharmaceutical Leucine Product Portfolio
  30. 8.5.5 Hubei Bafeng Pharmaceutical Recent Developments
  31. 8.6 Jinghai Amino Acid
  32. 8.6.1 Jinghai Amino Acid Company Information
  33. 8.6.2 Jinghai Amino Acid Business Overview
  34. 8.6.3 Jinghai Amino Acid Leucine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinghai Amino Acid Leucine Product Portfolio
  36. 8.6.5 Jinghai Amino Acid Recent Developments
  37. 8.7 JIRONG PHARM
  38. 8.7.1 JIRONG PHARM Company Information
  39. 8.7.2 JIRONG PHARM Business Overview
  40. 8.7.3 JIRONG PHARM Leucine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 JIRONG PHARM Leucine Product Portfolio
  42. 8.7.5 JIRONG PHARM Recent Developments
  43. 8.8 Jiahe Biotech
  44. 8.8.1 Jiahe Biotech Company Information
  45. 8.8.2 Jiahe Biotech Business Overview
  46. 8.8.3 Jiahe Biotech Leucine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jiahe Biotech Leucine Product Portfolio
  48. 8.8.5 Jiahe Biotech Recent Developments
  49. 8.9 ChuyuanGroup
  50. 8.9.1 ChuyuanGroup Company Information
  51. 8.9.2 ChuyuanGroup Business Overview
  52. 8.9.3 ChuyuanGroup Leucine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ChuyuanGroup Leucine Product Portfolio
  54. 8.9.5 ChuyuanGroup Recent Developments
  55. 8.10 Siwei Amino Acid
  56. 8.10.1 Siwei Amino Acid Company Information
  57. 8.10.2 Siwei Amino Acid Business Overview
  58. 8.10.3 Siwei Amino Acid Leucine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Siwei Amino Acid Leucine Product Portfolio
  60. 8.10.5 Siwei Amino Acid Recent Developments
  61. 8.11 SHINE STAR（HUBEI）BLOLOGICAL
  62. 8.11.1 SHINE STAR（HUBEI）BLOLOGICAL Company Information
  63. 8.11.2 SHINE STAR（HUBEI）BLOLOGICAL Business Overview
  64. 8.11.3 SHINE STAR（HUBEI）BLOLOGICAL Leucine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 SHINE STAR（HUBEI）BLOLOGICAL Leucine Product Portfolio
  66. 8.11.5 SHINE STAR（HUBEI）BLOLOGICAL Recent Developments
  67. 8.12 JiangsuShenhua Pharmaceutical
  68. 8.12.1 JiangsuShenhua Pharmaceutical Company Information
  69. 8.12.2 JiangsuShenhua Pharmaceutical Business Overview
  70. 8.12.3 JiangsuShenhua Pharmaceutical Leucine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 JiangsuShenhua Pharmaceutical Leucine Product Portfolio
  72. 8.12.5 JiangsuShenhua Pharmaceutical Recent Developments
  73. 8.13 ZhangjiagangxingyuTechnology
  74. 8.13.1 ZhangjiagangxingyuTechnology Company Information
  75. 8.13.2 ZhangjiagangxingyuTechnology Business Overview
  76. 8.13.3 ZhangjiagangxingyuTechnology Leucine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ZhangjiagangxingyuTechnology Leucine Product Portfolio
  78. 8.13.5 ZhangjiagangxingyuTechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Leucine Value Chain Analysis
  2. 9.1.1 Leucine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Leucine Sales Mode & Process
  6. 9.2 Leucine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Leucine Distributors
  9. 9.2.3 Leucine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst